Utility of late gadolinium enhancement in pediatric cardiac MRI

Pediatric Radiology

Volumn 46, Issue 8, 2016, Pages 1096-1113

  Etesami, Maryam ^a   Gilkeson, Robert C ^a   Rajiah, Prabhakar ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Children; Gadolinium; Heart; Late gadolinium enhancement; Magnetic resonance imaging; Myocardium

Indexed keywords

GADOLINIUM; CONTRAST MEDIUM;

AORTA STENOSIS; CARDIAC MUSCLE; CARDIOMYOPATHY; CARDIOVASCULAR MAGNETIC RESONANCE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONGESTIVE CARDIOMYOPATHY; CONTRAST ENHANCEMENT; CORONARY ARTERY ANOMALY; CORONARY ARTERY DISSECTION; CORONARY ARTERY FISTULA; DANON DISEASE; FABRY DISEASE; HEART INFARCTION; HEART RIGHT VENTRICLE DYSPLASIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMAGE ANALYSIS; MUCOCUTANEOUS LYMPH NODE SYNDROME; MYOCARDIAL BRIDGING; NEOPLASM; PEDIATRICS; PERICARDITIS; PRIORITY JOURNAL; REVIEW; SARCOIDOSIS; THROMBUS; CHILD; DIAGNOSTIC IMAGING; HEART; HEART DISEASE; IMAGE ENHANCEMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PROCEDURES;

CHILD; CONTRAST MEDIA; GADOLINIUM; HEART; HEART DISEASES; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING;

EID: 84952667515     PISSN: 03010449     EISSN: 14321998     Source Type: Journal    
DOI: 10.1007/s00247-015-3526-2     Document Type: Review

References (98)

1. Meng H, Grosse-Wortmann L (2012) Gadolinium in pediatric cardiovascular magnetic resonance: what we know and how we practice. J Cardiovasc Magn Reson 14:56
2. ACR Committee on Drugs and Contrast Media (2015) Manual on contrast media, version 10.1. http://www.acr.org/Quality-Safety/Resources/Contrast-Manual. Accessed 5 Nov 2015
3. Klumpp B, Fenchel M, Hoeverlborn T et al (2006) Assessment of myocardial viability using delayed enhancement magnetic resonance imaging at 3.0 tesla. Investig Radiol 41:661–667
4. Kellman P, Arai AE (2012) Cardiac imaging techniques for physicians: late enhancement. J Magn Reson Imaging 36:529–542
5. Fratz S, Chung T, Greil GF et al (2013) Guidelines and protocols for cardiovascular magnetic resonance in children and adults with congenital heart disease: SCMR expert consensus group on congenital heart disease. J Cardiovasc Magn Reson 13:15–51
6. Kellenberger CJ, Yoo SJ, Buchel ERV (2007) Cardiovascular MR imaging in neonates and infants with congenital heart disease. Radiographics 27:5–18
7. Bailliard F, Hughes ML, Taylor AM (2008) Introduction to cardiac imaging in infants and children: techniques, potential, and role in the imaging work-up of various cardiac malformations and other pediatric heart conditions. Eur J Radiol 68:191–198
8. Ntsinjana HN, Hughes ML, Taylor AM (2011) The role of cardiovascular magnetic resonance in pediatric congenital heart disease. J Cardiovasc Magn Reson 13:51
9. Harris MA, Johnston TR, Weinberg PM et al (2007) Delayed-enhancement cardiovascular magnetic resonance identifies fibrous tissue in children after surgery for congenital heart disease. J Thorac Cardiovasc Surg 133:676–681
10. Oosterhof T, Mulder BJM, Vliegen HW et al (2005) Corrected tetralogy of Fallot: delayed enhancement in right ventricular outflow tract. Radiology 237:868–871
11. Taylor AM, Dymarkowski S, Hamaekers P et al (2005) MR coronary angiography and late enhancement myocardial MR in children who underwent arterial switch surgery for transposition of great arteries. Radiology 234:542–547
12. Ylitalo P, Pitkanen OM, Lauerma K et al (2014) Late gadolinium enhancement (LGE) progresses with right ventricle volume in children after repair of tetralogy of Fallot. IJC Heart Vessel 3:15–20
13. Preim U, Sommer P, Hoffmann J et al (2014) Delayed enhancement imaging in a contemporary patient cohort following correction of tetralogy of Fallot. Cardiol Young 10:1–8
14. Babu-Narayanan SV, Kilner PJ, Li W et al (2006) Ventricular fibrosis suggested by cardiovascular magnetic resonance in adults with repaired tetralogy of Fallot and its relationship to adverse markers of clinical outcome. Circulation 113:405–413
15. Wald RM, Haber I, Wald R et al (2009) Effects of regional dysfunction and late gadolinium enhancement on global right ventricular function and exercise capacity in patients with repaired tetralogy of Fallot. Circulation 119:1370–1377
16. Babu-Narayanan SV, Goktekin O, Moon JC et al (2005) Late gadolinium enhancement cardiovascular magnetic resonance of the systemic right ventricle in adults with previous atrial redirection surgery for transposition of the great arteries. Circulation 111:2091–2098
17. Rathod RH, Prakash A, Powell AJ et al (2010) Myocardial fibrosis identified by cardiac magnetic resonance late gadolinium enhancement is associated with adverse ventricular mechanics and ventricular tachycardia late after Fontan operation. J Am Coll Cardiol 55:1721–1728
18. Rathod RH, Prakash A, Kim YY et al (2014) Cardiac magnetic resonance parameters predict transplantation-free survival in patients with Fontan circulation. Circ Cardiovasc Imaging 7:502–509
19. Rajiah P, Setser RM, Desai MY et al (2011) Utility of free-breathing, whole-heart three-dimensional magnetic resonance imaging in the assessment of coronary artery anatomy for congenital heart disease. Pediatr Cardiol 32:418–425
20. Febbo JA, Galizia MS, Murphy IG et al (2015) Congenital heart disease in adults: quantitative and qualitative evaluation of IR FLASH and IR SSFP MRA techniques using a blood pool contrast agent in the steady state and comparison to first pass MRA. Eur J Radiol 84:1921–1929
21. Gharib AM, Ho VB, Rosing DR et al (2008) Coronary artery anomalies and variants: technical feasibility of assessment with coronary MR angiography at 3T. Radiology 247:220–229
22. Sakuma H (2011) Coronary CT versus MR angiography: the role of MR angiography. Radiology 258:340–349
23. Dewey M (2011) Coronary CT versus MR angiography: pro CT — the role of CT angiography. Radiology 258:329–339
24. Rehwald WG, Fieno DS, Chen EL et al (2002) Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury. Circulation 105:224–229
25. Kim RJ, Wu F, Rafael A et al (2000) The use of contrast enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 343:1445–1453
26. Rajiah P, Desai MY, Kwon D et al (2013) MR imaging of myocardial infarction. Radiographics 33:1383–1412
27. Mavrogeni S, Papadopoulos G, Douskou M et al (2006) Magnetic resonance angiography, function and viability evaluation in patients with Kawasaki disease. J Cardiovasc Magn Reson 8:493–498
28. Greil GF, Stuber M, Botnar RM et al (2002) Coronary magnetic resonance angiography in adolescents and young adults with Kawasaki disease. Circulation 105:908–911
29. Tacke CE, Romeih S, Kuipers IM et al (2013) Evaluation of cardiac function by magnetic resonance imaging during the follow-up of patients with Kawasaki disease. Circ Cardiovasc Imaging 6:67–73
30. Lipsett J, Cohle SD, Berry PJ et al (1994) Anomalous coronary arteries: a multicenter pediatric autopsy study. Pediatr Pathol 14:287–300
31. Kaushal S, Backer CL, Popescu AR et al (2011) Intramural coronary length correlates with symptoms in patients with anomalous aortic origin of the coronary artery. Ann Thorac Surg 92:986–991
32. Sunder KR, Balakrishnan KG, Tharakan JA et al (1997) Coronary artery fistula in children and adults: a review of 25 cases with long-term observations. Int J Cardiol 58:47–53
33. Saboo SS, Juan YH, Khandelwal A et al (2014) MDCT of congenital coronary artery fistulas. AJR Am J Roentgenol 203:W244–W252
34. Möhlenkamp S, Hort W, Ge J et al (2002) Update on myocardial bridging. Circulation 106:2616–2622
35. Sharma J, Hellenbrand W, Kleinman C et al (2011) Symptomatic myocardial bridges in children: a case report with review of literature. Cardiol Young 21:490–494
36. La Salvia EA, Gilkeson RC, Dahms BB et al (2006) Delayed contrast enhancement magnetic resonance imaging in congenital aortic stenosis. Pediatr Cardiol 27:388–390
37. Azevedo CF, Nigri M, Higuchi ML et al (2010) Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease. J Am Coll Cardiol 56:278–287
38. Robinson JD, Del Nido PJ, Geggel RL et al (2010) Left ventricular diastolic heart failure in teenagers who underwent balloon aortic valvuloplasty in early infancy. Am J Cardiol 106:426–429
39. Alvarez JA, Orav EJ, Wilkinson JD et al (2011) Competing risks for death and cardiac transplantation in children with dilated cardiomyopathy: results from the pediatric cardiomyopathy registry. Circulation 124:814–823
40. McCrohon JA, Moon JC, Prasad SK et al (2003) Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 108:54–59
41. Masci PG, Schuurman R, Andrea B et al (2013) Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study. Circ Cardiovasc Imaging 6:790–799
42. Koutalas E, Kanoupakis E, Vardas P (2013) Sudden cardiac death in non-ischemic dilated cardiomyopathy: a critical appraisal of existing and potential risk stratification tools. Int J Cardiol 167:335–341
43. Latus H, Gummel K, Klingel K et al (2015) Focal myocardial fibrosis assessed by late gadolinium enhancement cardiovascular magnetic resonance in children and adolescents with dilated cardiomyopathy. J Cardiovasc Magn Reson 17:34
44. Ho CY (2010) Genetics and clinical destiny: improving care in hypertrophic cardiomyopathy. Circulation 122:2430–2440
45. To AC, Dillon A, Desai MY (2011) Cardiac magnetic resonance in hypertrophic cardiomyopathy. JACC Cardiovasc Imaging 4:1123–1137
46. Kwon DH, Smedira NG, Rodriguez ER et al (2009) Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia. J Am Coll Cardiol 54:242–249
47. Hussain T, Dragulescu A, Benson L et al (2015) Quantification and significance of diffuse myocardial fibrosis and diastolic dysfunction in childhood hypertrophic cardiomyopathy. Pediatr Cardiol 36:970–978
48. Smith BM, Dorfman AL, Yu S et al (2014) Clinical significance of late gadolinium enhancement in patients <20 years of age with hypertrophic cardiomyopathy. Am J Cardiol 113:1234–1239
49. Chaowu Y, Shihua Z, Jian L et al (2013) Cardiovascular magnetic resonance characteristics in children with hypertrophic cardiomyopathy. Circ Heart Fail 6:1013–1020
50. Ellims AH, Iles LM, Ling LH et al (2014) A comprehensive evaluation of myocardial fibrosis in hypertrophic cardiomyopathy with cardiac magnetic resonance imaging: linking genotype with fibrotic phenotype. Eur Heart J Cardiovasc Imaging 15:1108–1116
51. Rubinshtein R, Glockner JF, Ommen SR et al (2010) Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy. Circ Heart Fail 3:51–58
52. Spinner JA, Noel CV, Denfield SW et al (2013) Utility of late gadolinium enhancement and left ventricular mass as assessed by cardiac magnetic resonance in children with hypertrophic cardiomyopathy. Circulation 128:A17300
53. Marcus FI, McKenna WJ, Sherrill D et al (2010) Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation 121:1533–1541
54. Jain A, Tandri H, Calkins H et al (2008) Role of cardiovascular magnetic resonance imaging in arrhythmogenic right ventricular dysplasia. J Cardiovasc Magn Reson 10:32
55. Te Riele AS, Tandri H, Bluemke DA (2014) Arrhythmogenic right ventricular cardiomyopathy (ARVC): cardiovascular magnetic resonance update. J Cardiovasc Magn Reson 16:50
56. Tandri H, Saranathan M, Rodriguez ER et al (2005) Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. J Am Coll Cardiol 45:98–103
57. Tandri H, Macedo R, Calkins H et al (2008) Role of magnetic resonance imaging in arrhythmogenic right ventricular dysplasia: insights from the North American arrhythmogenic right ventricular dysplasia (ARVD/C) study. Am Heart J 155:147–153
58. Etoom Y, Govindapillai S, Hamilton R et al (2014) Importance of CMR within the task force criteria for the diagnosis of ARVC in children and adolescents. J Am Coll Cardiol 65:987–995
59. Petersen SE, Selvanayagam JB, Wiesmann F et al (2005) Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol 46:101–105
60. Cheng H, Lu M, Hou C et al (2015) Comparison of cardiovascular magnetic resonance characteristics and clinical consequences in children and adolescents with isolated left ventricular non-compaction with and without late gadolinium enhancement. J Cardiovasc Magn Reson 17:44
61. Wan J, Zhao S, Cheng H et al (2013) Varied distributions of late gadolinium enhancement found among patients meeting cardiovascular magnetic resonance criteria for isolated left ventricular non-compaction. J Cardiovasc Magn Reson 15:20
62. Nucifora G, Aquaro GD, Pingitore A et al (2011) Myocardial fibrosis in isolated left ventricular non-compaction and its relation to disease severity. Eur J Heart Fail 13:170–176
63. Vignaux O (2005) Cardiac sarcoidosis: spectrum of MRI features. AJR Am J Roentgenol 184:249–254
64. Watanabe E, Kimura F, Nakajima T et al (2013) Late gadolinium enhancement in cardiac sarcoidosis: characteristic magnetic resonance findings and relationship with left ventricular function. J Thorac Imaging 28:60–66
65. Greulich S, Deluigi CC, Gloekler S et al (2013) CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. JACC Cardiovasc Imaging 6:501–511
66. Vignaux O, Dhote R, Duboc D et al (2002) Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study. Chest 122:1895–1901
67. Nakao S, Takanaka T, Maoda M et al (1995) An atypical variant of Fabry’s disease in man with left ventricular hypertrophy. N Engl J Med 33:288–293
68. Sachdev B, Takanaka T, Teraguchi H et al (2002) Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy. Circulation 105:1407–1411
69. Chimenti C, Pieroni M, Morgante E et al (2004) Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy. Circulation 110:1047–1053
70. Moon JC, Sheppard M, Reed E et al (2006) The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry disease. J Cardiovasc Magn Reson 8:479–482
71. De Cobelli F, Esposito A, Belloni E et al (2009) Delayed-enhanced cardiac MRI for differentiation of Fabry’s disease from symmetric hypertrophic cardiomyopathy. AJR Am J Roentgenol 192:W97–W102
72. Krämer J, Niemann M, Störk S et al (2014) Relation of burden of myocardial fibrosis to malignant ventricular arrhythmias and outcomes in Fabry disease. Am J Cardiol 114:895–900
73. Yang Z, McMahon CJ, Smith LR et al (2005) Danon disease as an underrecognized cause of hypertrophic cardiomyopathy in children. Circulation 112:1612–1617
74. Piotrowska-Kownacka D, Kownacki L, Kuch M et al (2009) Cardiovascular magnetic resonance findings in a case of Danon disease. J Cardiovasc Magn Reson 11:12
75. Tada H, Harimura Y, Yamasaki H et al (2010) Utility of real-time 3-dimensional echocardiography and magnetic resonance imaging for evaluation of Danon disease. Circulation 121:e390–e392
76. Dara BS, Rusconi PG, Fishman JE (2011) Danon disease: characteristic late gadolinium enhancement pattern on cardiac magnetic resonance imaging. Cardiol Young 21:707–709
77. Silva MC, Meira ZM, Gurgel Giannetti J et al (2007) Myocardial delayed enhancement by magnetic resonance imaging in patients with muscular dystrophy. J Am Coll Cardiol 49:1874–1879
78. Hor KN, Taylor MD, Al-Khalidi HR et al (2013) Prevalence and distribution of late gadolinium enhancement in a large population of patients with Duchenne muscular dystrophy: effect of age and left ventricular systolic function. J Cardiovasc Magn Reson 15:107
79. Puchalski MD, Williams RV, Askovich B et al (2009) Late gadolinium enhancement: precursor to cardiomyopathy in Duchenne muscular dystrophy? Int J Cardiovasc Imaging 25:57–63
80. Dittrich S, Tuerk M, Haaker G et al (2015) Cardiomyopathy in Duchenne muscular dystrophy: current value of clinical, electrophysiological and imaging findings in children and teenagers. Klin Padiatr 227:225–231
81. Walcher T, Steinbach P, Spiess J et al (2011) Detection of long-term progression of myocardial fibrosis in Duchenne muscular dystrophy in an affected family: a cardiovascular magnetic resonance study. Eur J Radiol 80:115–119
82. Yilmaz A, Gdynia HJ, Ludolph AC et al (2010) Images in cardiovascular medicine. Cardiomyopathy in a Duchenne muscular dystrophy carrier and her diseased son: similar pattern revealed by cardiovascular MRI. Circulation 121:e237–e239
83. Friedrich MG, Sechtem U, Schulz-Menger J et al (2009) Cardiovascular magnetic resonance in myocarditis: a JACC white paper. J Am Coll Cardiol 53:1475–1487
84. Sachdeva S, Song X, Dham N et al (2015) Analysis of clinical parameters and cardiac magnetic resonance imaging as predictors of outcome in pediatric myocarditis. Am J Cardiol 115:499–504
85. Zagrosek A, Abdel-Aty H, Boye P et al (2009) Cardiac magnetic resonance monitors: reversible and irreversible myocardial injury in myocarditis. JACC: Cardiovasc Imaging 2:131–138
86. Wagner A, Schulz-Menger J, Dietz R et al (2003) Long-term follow-up of patients with acute myocarditis by magnetic resonance imaging. MAGMA 16:17–20
87. Mahrholdt H, Wagner A, Deluigi CC et al (2006) Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 114:1581–1590
88. Zurick AO, Bolen MA, Kwon DH et al (2011) Pericardial delayed hyperenhancement with CMR imaging in patients with constrictive pericarditis undergoing surgical pericardiectomy: a case series with histopathological correlation. JACC Cardiovasc Imaging 4:1180–1191
89. Rajiah P (2011) Cardiac MRI: part 2, pericardial diseases. AJR Am J Roentgenol 197:W621–W634
90. Feng D, Glockner J, Kim K et al (2011) Cardiac magnetic resonance imaging pericardial late gadolinium enhancement and elevated inflammatory markers can predict the reversibility of constrictive pericarditis after anti-inflammatory medical therapy: a pilot study. Circulation 124:1830–1837
91. Weinsaft JW, Kim HW, Shah DJ et al (2008) Detection of left ventricular thrombus by delayed-enhancement cardiovascular magnetic resonance prevalence and markers in patients with systolic dysfunction. J Am Coll Cardiol 52:148–157
92. Lam KY, Dickens P, Chan AC (1993) Tumors of the heart. A 20-year experience with a review of 12,485 consecutive autopsies. Arch Pathol Lab Med 117:1027–1031
93. Tao TY, Yahyavi-Firouz-Abadi N, Singh GK et al (2014) Pediatric cardiac tumors: clinical and imaging features. Radiographics 34:1031–1046
94. Beroukhim RS, Prakash A, Buechel ER et al (2011) Characterization of cardiac tumors in children by cardiovascular magnetic resonance imaging: a multicenter experience. J Am Coll Cardiol 58:1044–1054
95. Grebenc ML, Rosado de Christenson ML, Burke AP et al (2000) Primary cardiac and pericardial neoplasms: radiologic– pathologic correlation. Radiographics 20:1073–1103
96. Ghadimi Mahani M, Lu JC, Rigsby CK et al (2014) MRI of pediatric cardiac masses. AJR Am J Roentgenol 202:971–981
97. Huh J, Noh CI, Kim YW et al (1999) Secondary cardiac tumor in children. Pediatr Cardiol 20:400–403
98. Sparrow PJ, Kurian JB, Jones TR et al (2005) MR imaging of cardiac tumors. Radiographics 25:1255–1276